Achilles Therapeutics plc - ADR logo

Achilles Therapeutics plc - ADR (698)

Market Open
1 Apr, 20:00
XFRA XFRA
1. 33
0
0%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
1.33
Previous Close
Day Range
1.33 1.33
Year Range
0.59 1.36
Earnings results expected in 4 days
Want to track 698 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
6 May 2025 (4 Days)
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
11 Nov 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
26 Aug 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
14 Aug 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
5 Aug 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
2 Aug 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
8 May 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
27 Mar 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
8 Mar 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
6 Mar 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
5 Mar 2024
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
13 Nov 2023
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
9 Nov 2023
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
8 Nov 2023
-
Cons. EPS
-
EPS
Achilles Therapeutics plc - ADR logo
698 Achilles Therapeutics plc - ADR
6 Nov 2023
-
Cons. EPS
-
EPS